Last reviewed · How we verify
Opioid Overdose Education
Opioid Overdose Education is an educational program that teaches recognition and response to opioid overdose events, including the use of naloxone (an opioid antagonist) to reverse overdose.
Opioid Overdose Education is an educational program that teaches recognition and response to opioid overdose events, including the use of naloxone (an opioid antagonist) to reverse overdose. Used for Opioid overdose prevention and emergency response training.
At a glance
| Generic name | Opioid Overdose Education |
|---|---|
| Also known as | Narcan |
| Sponsor | University of Alabama at Birmingham |
| Modality | Small molecule |
| Therapeutic area | Public Health / Addiction Medicine |
| Phase | FDA-approved |
Mechanism of action
This is not a pharmaceutical drug but rather a public health educational intervention developed by the University of Alabama at Birmingham. It focuses on training individuals to identify signs of opioid overdose and administer naloxone, which competitively blocks opioid receptors and rapidly reverses opioid-induced respiratory depression and other overdose symptoms.
Approved indications
- Opioid overdose prevention and emergency response training
Common side effects
Key clinical trials
- Kentucky Women's Justice Community Overdose Innovation Network - Phase II (NA)
- Machine-Learning Prediction and Reducing Overdoses With EHR Nudges (NA)
- Social Network Overdose Prevention and Education Intervention (NA)
- Reducing Overdose and Substance Use-related Stigma by Training Non-substance-using Friends and Family Members of People Who Use Opioids to Be Harm Reduction Champions (NA)
- TechMPower: Advancing HIV/SUD Care and Service Delivery for People in Re-entry (NA)
- A Social Network Approach to Improve HIV Prevention and Substance Use Treatment For People Who Use Drugs (NA)
- Preoperative Education for Less Outpatient Pain After Surgery (PELOPS) (NA)
- Mobile Peer Support for OUD Recovery (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Opioid Overdose Education CI brief — competitive landscape report
- Opioid Overdose Education updates RSS · CI watch RSS
- University of Alabama at Birmingham portfolio CI